Anti-SP110 antibodies are used in the immunodetection of the protein SP110 nuclear body protein. In humans, the canonical protein has a reported length of 689 amino acid residues and a mass of 78.4 kDa. Its subcellular localization is in the nucleus. Up to 7 different isoforms have been reported for this protein. It is reported to be highly expressed in peripheral blood leukocytes and spleen. SP110 is known to be a type of transcription factor. Post-translational modifications have been described, including phosphorylation. The SP110 gene has been associated with the disease, Hepatic venoocclusive disease with immunodeficiency. Synonyms for this target antigen include IFI75, IPR1, VODI, interferon-induced protein 41, 30kD, interferon-induced protein 41/75, and IFI41. SP110 gene orthologs have been reported in the mouse, rat, bovine and chimpanzee species. Some SP110 antibodies may have been used in research and have associated citations. Western Blot is a widely used application for these antibodies. ELISA and Immunohistochemistry are also common applications.